Looking for a new career opportunity? qPharmetra is always interested in talented people who share our vision of better decisions, better medicines and will thrive with our creative, collaborative and consistent way of working. More information @qP/Careers Compliance Manager Senior […]
qpNCA is the latest free software initiative from qPharmetra. Implemented as an R library, it conducts noncompartmental analysis (NCA) for PK or PD profiles (e.g. drug concentration vs. time). Features include:• Calculations of all essential NCA parameters for intravenous bolus […]
Check out our Experts page for more information, click here.We’re hiring pharmacometricians in the US and EU who love to work with data.
Newer versions of R mean an update to the Argo environment for reproducible pharmacometric data sciences. Very soon, we will release this new containerized environment for free download. Stay tuned. Check out: https://qpharmetra.com/software/argo/
This latest version of qP’s non-compartmental analysis package, initiated in 2017, now includes input data availability checks. Again, it is validated against a substantial set of test PK curves to guarantee proper execution. The package, validation documentation and User’s guide […]
Highly motivated to create a consulting practice providing consistent work product, and, admittedly, also with an entrepreneurial ambition, a group of 4 seasoned pharmacometric consultants … read more
Check out this new publication in Clinical Cancer Research co-authored by qPharmetra’s Clinical Pharmacology Consultant Ben Suttle. It is yet another great example of Ben’s extensive industry experience in the development of medications in the field of Oncology: https://lnkd.in/g3kTDmV
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque blandit elementum erat vel tempus. Donec facilisis odio non orci fermentum accumsan. Aliquam non nibh ut nisi mollis cursus. Praesent feugiat aliquet aliquam.
We use these three core values – creativity , collaboration and consistency – in all our work to serve our clients and ultimately serve the patients with better medicines.
We are over 20 scientists with extensive experience located in the US and Europe. We work closely together and share knowledge to help our clients make better decisions.
Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.